Gilead wins appeals court ruling against overseas drug imports

Gilead Sciences has secured a legal victory in an appeals court ruling concerning the unauthorized importation of its pharmaceutical products from overseas markets. The decision reinforces the company's ability to control its domestic supply chain and protect its intellectual property rights against gray-market imports. This ruling is significant for the pharmaceutical sector as it provides a legal precedent for drug manufacturers seeking to prevent the sale of medications intended for foreign markets within the United States.